Attend ICNMDigital 2023, virtual scientific update on neuromuscular diseases, while we wait for our next gathering at ICNMD 2024 in October 2024.
The session on Muscle Disorders includes presentations by speakers who will update you on the effects of treatment in infantile-onset and late-onset Pompe disease (Dr. Nadine Van der Beek), on emerging therapeutic options in various subtypes of myositis (Andrew Mammen), and on recognition and causes of rhabdomyolysis (Prof. Benedikt Schoser).
In the session on Peripheral Neuropathies, Dr. Jeffrey Allen will present an update on the new classification of CIDP and variants no longer included; Dr. Roser Velasco will speak to immunotherapy and checkpoint inhibitors-related neuropathies; while Prof. Teresa Coelho will focus on amyloid associated neuropathies, esp. hATTR.
In the Neuromuscular Junction Disorders session, Dr. Carolina Barnett-Tapia will present patient assessment methods in myasthenia gravis, Prof. Vera Bril will provide an update on treatment of MG, and Prof. Jan Verschuuren will update us on LEMS.
The final session will address the current state of our understanding of ALS genetics (Dr. Eva Feldman), the utility of disease biomarkers (Prof. Philip Van Damme), the approach to drug treatment (Dr. Stephen Goutman) and finally palliative care (Prof. Orla Hardiman).
In addition to these scientific sessions, five industry-supported symposia will address new strategies for advancing care and protecting bone health in duchenne muscular dystrophy (Santhera), aging and infectious diseases in myasthenia gravis (Grifols), limb-girdle muscular dystrophies (Sarepta), continuity of care and the totality of evidence in nmDMD (PTC), and latest learnings about zolgensma treatment in SMA (Novartis).
An on-demand presentation by PTC on the journey of boys with nonsense mutation Duchenne muscular dystrophy rounds up this virtual event.
Register today!
Published on 29 November 2023.
